LESAKA TECHNOLOGIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data LESAKA TECHNOLOGIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	610	613	161	144	131	223	528	564	660	722
Cost of revenue	292	244	124	102	96.2	168	418	443	487	491
Gross profit	318	369	36.5	42	34.5	54.3	110	121	173	231
Research and development	2	0.8	0.7	1.6	0.3	0.5	0.5	0.5	0.5	0.8
Selling, general and administrative	179	131	145	75.3	84.1	75	95.1	87	124	153
Operating income	97	53.8	-135	-44.2	-53.9	-40.2	-15.3	2.75	-28	12.7
Interest expense	3.48	8.94	9.86	7.64	2.98	5.83	18.6	19.2	21.8	18.5
Interest income	20.9	17.9
Pre-tax income	114	94.6	-319	-65	-5.62	-39.9	-32.3	-13.9	-107	3.73
Income tax	42.5	45.1	-5.07	2.66	7.56	0.33	-2.31	3.36	-16	1.43
Income from continuing operations	73.1	52.1	-312	-97.2	-38.1	-43.9
Net income to minority interests	1.69	-0.88	2.35	0	0		0	0	-0.13	-0.25
Net income	73.1	62.1	-311	-78.4	-38.1	-43.9	-35.1	-18.5	-91	2.76
EBITDA	138	89.3	-97.6	-30.9	-49.5	-32.6	8.34	26.4	5.76	60
EPS, basic	1.44	1.18	-5.89	-1.47	-0.72	-0.81	-0.60	-0.29	-1.19	0.03
EPS, diluted	1.43	1.17	-5.89	-1.47	-0.72	-0.81	-0.60	-0.29	-1.19	0.03
Shares, basic (weighted)	50.2	0.05	52.1	52.1	52.4	53.3	56	61.3	73.9	79.5
Shares, diluted (weighted)	50.3	0.05	52.1	52.1	52.7	53.3	56	61.3	73.9	79.7

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	258	90.1	46.1	218	199	43.9	35.5	59.1	76.5	81.4
Receivables	111	110	31.1	43.1	26.6	28.9	25.7	36.7	42.5	104
Inventory	8.02	10.4	5.71	19.9	22.4	34.2	27.3	18.2	23.6	20.1
Total current assets	1,106	427	296	319	294	218	164	188	244	268
Property, plant and equipment	39.4	25.7	8.23	6.66	7.49	24.6	27.4	31.9	44.9	50.2
Lease right-of-use assets			0	5.4	4.52	7.15	4.73	7.28	9.69	20.2
Goodwill	75.6	52.8	37.3	24.2	29.2	163	134	139	199	215
Intangible assets	38.8	27.1	2.23	0.61	0.36	157	122	111	139	123
Other non-current assets	49.7	235	28.8	31.3	81.9	78.1	77.6	78	3.81	9.7
Total assets	1,451	1,217	670	454	428	657	542	558	651	699
Accounts payable	15.1	21.1	9.87	6.29	7.11	18.6	12.4	16.7	19.9	24
Accrued liabilities	10.9	16.1	8.04	6.05	7.5	9.95	7.08	7.17	8.47	10.6
Short-term debt	8.74	44.1	0		0	142	3.66	15.7	12	16.1
Total current liabilities	721	283	238	71.3	52.5	146	102	130	164	169
Long-term debt	7.5	5.47	0		0	135	129	127	189	195
Lease liabilities				3.31	1.89	4.83	3.14	5.09	6.13	19.3
Other non-current liabilities	2.8	30.3	2.5	2.01	2.58	2.47	1.98	2.6	2.99	3.99
Total liabilities	743	373	245	78.5	67.4	342	283	303	396	415
Total debt	16.2	50.2	0		0	142	133	143	201	211
Paid-in capital	274	276	277	301	302	328	336	344	136	153
Retained earnings	773	836	523	445	407	363	328	310	217	219
Treasury stock	-287	-287	-287	-287	-287	-287	-288	-290	-7.06	-0.23
Other comprehensive income	-163	-184	-196	-169	-146	-169	-196	-188	-186	-166
Shareholders' equity	598	641	317	290	276	235	179	176	159	205
Minority interests	2.77	95.9	0	0	0	0	0	0	6.84	0
Total equity	599	735	317	290	276	235	178	173	166	205
Total liabilities and equity	1,451	1,217	670	454	428	657	542	558	651	699
Shares outstanding	52.5	52.8	52.7	53.2	52.8	58	59.3	64.3	81.2	83.3

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	74.8	61.2	-309	-78.4	-38.1	-43.9	-35.1	-18.5	-91.1	2.51
Depreciation and amortization	41.4	35.5	37.3	13.3	4.35	7.58	23.7	23.7	33.7	47.3
Stock-based compensation	1.98	2.61	0.39	1.73	0.34	2.96	7.31	7.91	9.55	6.97
Deferred income tax	-0.01	10.1	-8.92	0.93	6.69	-2.04	-7.44	-2.71	-21.7	-9.45
Change in inventory	3.03	-2.52	4.04	-19.3	1.28	-4.82	2.17	9.84	0.17	6.7
Change in payables	-6.46	10.6	-14.5	-0.14	-0.34	-8.85	1.71	23.2	-12.2	19.8
Cash from operations	97.2	132	-4.46	-46	-58.4	-37.2	0.41	28.8	-9.12	52.4
Capital expenditures	-11.2	-9.65	-9.42	-5.94	-4.29	-4.56	-16.2	-12.7	-17.2	-20.6
Acquisitions	-4.65	-6.2	0	0	0	-202	0	-1.58	-12.9	-11.1
Cash from investing	-114	181	64.5	223	47.8	-194	-16.5	-16.4	-11.3	-25.7
Debt issued	0.8
Debt repaid	-37.3	-77.1	-37.4	-14.5	0	-5.58	-17.5	-20.1	-150	-13.7
Stock issued	47.9		0	0	0.05	0.76	0.48	0.17	0.12	0.06
Share buybacks	-45.8				0	0	-1.29	-1.5	-13.7	-0.34
Cash from financing	40.5	-473	-24.7	-48.8	-13.1	122	-19.1	-7.11	29.7	-27
Exchange rate effect	11.3	-7.98	-3.85	-17.3	15
Net change in cash	34.8	-168	31.5	111	-8.72	-119	-46.2	7.29	10.7	4.9
Free cash flow	86	123	-13.9	-52	-62.7	-41.8	-15.7	16.1	-26.3	31.8
Interest paid	3.71	8.65	10.6	6.05	3.06	5.82	13.3	17.4	18.1	21.8
Income taxes paid	45.2	41.1	13.1	5	16.6	1.14	7.2	6.51	6.48	10.4

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $4.18 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	32.0%	Gross profit / revenue.
Operating margin	1.8%	Operating income / revenue.
EBITDA margin	8.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	0.5%	Pre-tax income / revenue.
Net margin	0.4%	Net income / revenue.
FCF margin	4.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	7.3%	Cash from operations / revenue.
Effective tax rate	38.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	1.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.4%	Net income / average total assets.
Return on invested capital (ROIC)	2.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	0.1%	Research and development expense / revenue.
SG&A / revenue	21.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.9%	Capital expenditures / revenue.
D&A / revenue	6.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	9.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	11.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	40.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	33.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	27.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	46.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	943.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	93.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 3y	403.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	28.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	4.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-5.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	7.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	8.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	7.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	12.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	8.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.59x	Current assets / current liabilities.
Quick ratio	1.10x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.48x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.03x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	30.1%	Total debt / total assets.
Liabilities / assets	59.3%	Total liabilities / total assets.
Net debt	$129.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.15x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	0.69x	Operating income / interest expense.
Working capital	$99.1M	Current assets - current liabilities.
Goodwill and intangibles / assets	48.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$133.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.07x	Revenue / average total assets.
Fixed asset turnover	15.2x	Revenue / average property, plant and equipment.
Inventory turnover	22.5x	Cost of revenue / average inventory.
Days inventory	16 days	365 x average inventory / cost of revenue.
Receivables turnover	9.86x	Revenue / average receivables.
Days sales outstanding	37 days	365 x average receivables / revenue.
Days payables	16 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	37 days	Days inventory + days sales outstanding - days payables.
FCF conversion	1,153.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	39.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.03	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$0.03	Net income per basic share, as reported (split-adjusted).
Revenue per share	$9.06	Revenue / diluted weighted shares.
FCF per share	$0.40	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.66	Cash from operations / diluted weighted shares.
Book value per share	$2.47	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$1.60	Tangible book value / shares outstanding.
Cash per share	$0.98	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	1.1%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$358.6M	Share price x shares outstanding.
Enterprise value	$487.9M	Market cap + total debt - cash - short-term investments.
P/E	130x	Market cap / net income. Only when net income is positive.
P/S	0.50x	Market cap / revenue.
P/B	1.75x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	11.3x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	6.84x	Market cap / cash from operations, when positive.
EV/Sales	0.68x	Enterprise value / revenue.
EV/EBIT	38.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	8.13x	Enterprise value / EBITDA, when both are positive.
EV/FCF	15.3x	Enterprise value / free cash flow, when both are positive.
FCF yield	8.9%	Free cash flow / market cap.
Earnings yield	0.8%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.1%	(Dividends paid + share buybacks) / market cap.

What was LESAKA TECHNOLOGIES INC's revenue in fiscal 2026?

LESAKA TECHNOLOGIES INC reported revenue of $721.6M for fiscal 2026, 9.4% higher than the year before.

Was LESAKA TECHNOLOGIES INC profitable in fiscal 2026?

Yes. Net income was $2.8M, a net margin of 0.4%.

How much free cash flow did LESAKA TECHNOLOGIES INC generate in fiscal 2026?

Cash from operations of $52.4M minus capital expenditures of $20.6M left free cash flow of $31.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to LESAKA TECHNOLOGIES INC